Suppr超能文献

中药抗击新冠病毒的科学基础

The Scientific Foundation of Chinese Herbal Medicine against COVID-19.

作者信息

Leung Elaine Lai-Han, Pan Hu-Dan, Huang Yu-Feng, Fan Xing-Xing, Wang Wan-Ying, He Fang, Cai Jun, Zhou Hua, Liu Liang

机构信息

State Key Laboratory of Quality Research in Chinese Medicine & Macau Institute for Applied Research in Medicine and Health & Faculty of Chinese Medicine, Macau University of Science and Technology, Macao 999078, China.

出版信息

Engineering (Beijing). 2020 Oct;6(10):1099-1107. doi: 10.1016/j.eng.2020.08.009. Epub 2020 Sep 5.

Abstract

The recent coronavirus disease 2019 (COVID-19) pandemic outbreak has caused a serious global health emergency. Supporting evidence shows that COVID-19 shares a genomic similarity with other coronaviruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), and that the pathogenesis and treatment strategies that were applied 17 years ago in combating SARS-CoV and other viral infections could be taken as references in today's antiviral battle. According to the clinical pathological features of COVID-19 patients, patients can suffer from five steps of progression, starting with severe viral infection and suppression of the immune system and eventually progressing to cytokine storm, multi-organ damage, and lung fibrosis, which is the cause of mortality. Therefore, early prevention of disease progression is important. However, no specific effective drugs and vaccination are currently available, and the World Health Organization is urging the development of novel prevention and treatment strategies. Traditional Chinese medicine could be used as an alternative treatment option or in combination with Western medicine to treat COVID-19, due to its basis on historical experience and holistic pharmacological action. Here, we summarize the potential uses and therapeutic mechanisms of Chinese herbal formulas (CHFs) from the reported literature, along with patent drugs that have been recommended by institutions at the national and provincial levels in China, in order to verify their scientific foundations for treating COVID-19. In perspective, more basic and clinical studies with multiple high-tech and translational technologies are suggested to further confirm the therapeutic efficacies of CHFs.

摘要

最近爆发的2019冠状病毒病(COVID-19)疫情引发了严重的全球卫生紧急情况。支持性证据表明,COVID-19与其他冠状病毒,如严重急性呼吸综合征冠状病毒(SARS-CoV)和中东呼吸综合征冠状病毒(MERS-CoV),在基因组上具有相似性,并且17年前用于抗击SARS-CoV和其他病毒感染的发病机制及治疗策略可作为当今抗病毒斗争的参考。根据COVID-19患者的临床病理特征,患者病情可经历五个阶段,始于严重病毒感染和免疫系统抑制,最终发展为细胞因子风暴、多器官损伤和肺纤维化,而这正是导致死亡的原因。因此,早期预防疾病进展很重要。然而,目前尚无特效药物和疫苗,世界卫生组织正在敦促开发新的预防和治疗策略。由于基于历史经验和整体药理作用,中药可作为治疗COVID-19的替代治疗选择或与西药联合使用。在此,我们从已发表的文献中总结了中药复方(CHFs)的潜在用途和治疗机制,以及中国国家和省级机构推荐的专利药物,以验证其治疗COVID-19的科学依据。展望未来,建议开展更多采用多种高科技和转化技术的基础研究和临床研究,以进一步证实中药复方的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6109/7833648/92a7db8f3525/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验